ORA
Medical professionals - Top Left Highlight Image

For over 30 years, Ora has built successful partnerships with our valued clients, investors, and investigators.

Medical Professionals

30 years of experience. 30 NDA approvals.

Ora is the world’s leading independent ophthalmic product development firm, with more than 30 NDA approvals during its 30-year history. We have helped our clients garner these NDA approvals by providing strategic clinical-regulatory guidance and complete turnkey clinical-regulatory services, along every step of the development pathway.

Ora provides technology-based, concept-to-market services and solutions that accelerate development timelines and improve the scientific quality of clinical research. By doing so, we are able to help bring important new products to market faster, and improve patient care around the world.

About Us

We are a full-service drug and device development partner that helps our clients gain efficiencies at every step of the development process.  Our clients look to us to help them accelerate the pace of their drug development as they make the journey from concept to marketplace.

Research Departments

Recent News

Eyegate Pharma Annouces that EGP-437 Improved Signs and Symptoms of Dry Eye Syndrome in a Phase II Study

2009 06 03 Waltham, MA Based on the top level analysis of a Phase II study, EyeGate Pharma announces that EGP 437, a corticosteroid solution administered by a non invasive ocular drug delivery system, improved signs and symptoms in

Fovea Reports Positive Results with Prednisporin(TM) in Persistent Allergic Conjunctivitis

PARIS,France/PRNewswire/ -- Fovea Pharmaceuticals announced today positive results from its clinical proof-of-concept trial to assess the therapeutic effect of Prednisporin(TM) (FOV1101) in patients with persistent allergic conjunctivitis.